Trial Profile
A Randomized,Double-Blind , Placebo-Controlled Crossover Trial of Antivirals for Suppression of HSV and HIV Shedding in HIV-1, HSV-2 Co-infected Persons
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2023
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus type 2 infections; HIV-1 infections
- Focus Therapeutic Use
- 15 Dec 2008 Results published in The Journal of Infectious Diseases.
- 07 Jul 2007 New trial record.